Page 470 - IJB-9-2
P. 470

International Journal of Bioprinting                                            Bioprinting of exosomes



            aspect concerning this is the sterilization of produced EXOs.   Availability of data
            As a biological entity, EXOs contain many components,   Not applicable.
            including nucleic acids, such as DNA, mRNAs, miRNAs,
            proteins,  lipids,  etc.,  which  are  not  compatible  with   References
            conventional steam, radiation, or gas-based sterilization
            techniques . These techniques have the propensity to alter   1.   Doyle  LM,  Wang  MZ,  2019,  Overview  of  extracellular
                    [23]
            or inactivate the therapeutic cargo, thereby affecting the   vesicles,  their  origin,  composition, purpose,  and methods
            safety and efficacy of therapeutic EXOs. The 0.2 µm sterile   for exosome isolation and analysis. Cells, 8: 727.
            filtration technique is the standard technique adopted for   https://doi.org/10.3390/cells8070727
            manufacturing EXOs . However, this technique is not
                             [23]
            feasible for therapeutic particles bigger than 200 nm or   2.   Lin J, Li J, Huang B, et al., 2015, Exosomes: Novel biomarkers
            those that tend to undergo agglomeration. Additionally, for   for clinical diagnosis. Sci World J, 2015: 657086.
            commercial EXO products, residual protein or DNAs from   https://doi.org/10.1155/2015/657086
            producer cells that exist outside EXOs are still considered   3.   Bang C, Thum T, 2012, Exosomes: New players in cell-cell
            to be a component of EXOs, and thus part of the product   communication. Int J Biochem Cell Biol, 44: 2060–2064.
            itself . Therefore, it is essential to separate these unbound
                [90]
            impurities that might compromise the safety and efficacy   https://doi.org/10.1016/j.biocel.2012.08.007
            of produced EXOs. Other than that, EXO therapeutics   4.   Li N, Rochette L, Wu Y, et al., 2019, New insights into the
            should be tested for bacterial endotoxins, mycoplasma, and   role of exosomes in the heart after myocardial infarction.
            infectious viral load, including human immunodeficiency   J Cardiovasc Transl Res, 12: 18–27.
            virus I and II, hepatitis B and C viruses, cytomegalovirus,   https://doi.org/10.1007/s12265-018-9831-z
            Epstein–Barr virus, and parvovirus. Finally, as EXOs are   5.   Kim YG, Choi J, Kim K, 2020, Mesenchymal stem cell-
            considered to be a new class of drugs, investigators should   derived  exosomes  for  effective  cartilage  tissue  repair  and
            engage closely and proactively interact with regulatory   treatment of osteoarthritis. Biotechnol J, 15: e2000082.
            agencies to streamline protocols for the development of
            EXO-based therapeutics .                              https://doi.org/10.1002/biot.202000082
                               [90]
                                                               6.   Hur YH, Feng S, Wilson KF, et al., 2021, Embryonic stem
            Acknowledgments                                       cell-derived extracellular vesicles maintain ESC stemness by
                                                                  activating FAK. Dev Cell, 56: 277–291.e6.
            Not applicable.
                                                                  https://doi.org/10.1016/j.devcel.2020.11.017
            Funding                                            7.   Feng Z, Zhou J, Liu Y,  et al., 2021, Epithelium- and
                                                                  endothelium-derived  exosomes  regulate  the alveolar
            Not applicable.
                                                                  macrophages by targeting RGS1 mediated calcium
                                                                  signaling-dependent immune response.  Cell Death Differ,
            Conflict of interest                                  28: 2238–2256.
            The authors declare no known conflict of interest.    https://doi.org/10.1038/s41418-021-00750-x

            Author contributions                               8.   Zamani P, Fereydouni N, Butler AE,  et al., 2019, The
                                                                  therapeutic and diagnostic role of exosomes in cardiovascular
            Conceptualization  and  Visualization:  Arun  Chandru,   diseases. Trends Cardiovasc Med, 29: 313–323.
               Tuhin Bhowmick                                     https://doi.org/10.1016/j.tcm.2018.10.010
            Writing – original draft: Shivaram Selvam, Midhun Ben
               Thomas                                          9.   Liu J, Jiang F, Jiang Y,  et al., 2020, Roles of exosomes in
            Writing – review & editing: Shivaram Selvam, Midhun Ben   ocular diseases. Int J Nanomedicine, 15: 10519–10538.
               Thomas                                             https://doi.org/10.2147/ijn.S277190
                                                               10.  Hill AF, 2019, Extracellular vesicles and neurodegenerative
            Ethics approval and consent to participate            diseases. J Neurosci, 39: 9269–9273.
            Not applicable.                                       https://doi.org/10.1523/jneurosci.0147-18.2019
                                                               11.  Castaño C, Novials A, Párrizas M, 2019, Exosomes and
            Consent for publication                               diabetes. Diabetes Metab Res Rev, 35: e3107.

            Not applicable.                                       https://doi.org/10.1002/dmrr.3107



            Volume 9 Issue 2 (2023)                        462                          https://doi.org/10.18063/ijb.690
   465   466   467   468   469   470   471   472   473   474   475